Rocket Lab NASDAQ:RKLB, the global end-to-end space company, fell more than 10% to close at $85.41 on June 24, extending a correction of more than 43% from its all-time high as capital rotated to SpaceX and key executives sold shares.

Key Highlights

• Rocket Lab fell more than 10% to close at $85.41, extending a decline of more than 43% from its all-time high of $151 on May 27.

• Capital rotation from RKLB into the newly listed SpaceX has been a primary driver of the multi-week correction.

• Multiple key executives sold tens of millions of dollars in shares in mid-June, adding to supply overhang.

• Rocket Lab successfully launched an Electron mission on June 22, confirming ongoing operational execution.

Rocket Lab (NASDAQ:RKLB), a global end-to-end space company offering launch services via its Electron rocket and space systems solutions including spacecraft manufacturing and components, closed at $85.41 on June 24, down more than 10%, extending a correction that has now erased more than 43% from the all-time high of $151 reached on May 27.

The multi-week pullback has been driven by two structural forces. Post-SpaceX IPO capital rotation has drawn investor flows from established space names into the newly listed SPCX, reducing demand for RKLB shares as investors establish positions in the new listing. Separately, multiple key executives including the General Counsel sold tens of millions of dollars in shares in mid-June, creating meaningful supply overhang that has compounded the rotation-driven selling.

Operationally, the picture remains constructive. The company successfully launched another Electron mission on June 22, confirming the cadence of small satellite deployment services that underpins its near-term revenue base. Rocket Lab's broader ambition in the space systems business, including spacecraft manufacturing for government and commercial customers, represents a significant revenue diversification from launch services alone.

The divergence between operational execution and share price performance reflects the transient nature of post-IPO capital rotation effects rather than any fundamental reassessment of Rocket Lab's commercial prospects.